Design and implementation of a system for treating paediatric patients with stereotactically-guided conformal radiotherapy

被引:6
|
作者
Adams, EJ
Suter, BL
Warrington, AP
Black, P
Saran, F
Brada, M
机构
[1] Royal Marsden NHS Trust, Joint Dept Phys, Sutton SM2 5PT, Surrey, England
[2] Royal Marsden NHS Trust, Dept Radiotherapy, Sutton SM2 5PT, Surrey, England
[3] Royal Marsden NHS Trust, Neurooncol Unit, Sutton SM2 5PT, Surrey, England
关键词
fractionated stereotactic radiotherapy; immobilisation; paediatric radiotherapy; patient fixation; conformal radiotherapy;
D O I
10.1016/S0167-8140(01)00383-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Stereotactically-guided conformal radiotherapy (SCRT) allows the delivery of highly conformal dose distributions to localised brain tumours. This is of particular importance for children, whose often excellent long-term prognosis should be accompanied by low toxicity. The commercial immobilisation system in use at our hospital for adults was felt to be too heavy for children, and precluded the use of anaesthesia, which is sometimes required for paediatric patients. This paper therefore describes the design and implementation of a system for treating children with SCRT. This system needed to be well tolerated by patients, with good access for treating typical childhood malignancies. Materials and methods: A lightweight frame was developed for immobilisation, with a shell-based alternative for patients requiring general anaesthetic. Procedures were set up to introduce the patients to the frame system in order to maximise patient co-operation and comfort. Film measurements were made to assess the impact of the frame on transmission and surface dose. The reproducibility of the systems was assessed using electronic portal images. Results: Both frame and shell systems are in clinical use. The frame weighs 0.6 kg and is well tolerated. It has a transmission of 92-96%, and fields which pass through it deliver surface doses of 58-82% of the dose at d(max), compared to 18% when no frame is present. However, the frame is constructed to maximise the availability of unobstructed beam directions. Reproducibility measurements for the frame showed a mean random error of 1.0 +/- 0.2 mm in two dimensions (2D) and 1.4 +/- 0.7 mm in 3D. The mean systematic error in 3D was 2.2 mm, and 90% of all overall 3D errors were less than 3.4 mm. For the shell system, the mean 2D random error was 1.5 +/- 0.2 mm. Conclusions: Two well-tolerated immobilisation devices have been developed for fractionated SORT treatment of paediatric patients. A lightweight frame system gives a wide range of possible unobstructed beam directions, although beams that intersect the frame are not precluded, provided that output corrections are applied. A shell system allows the use of general anaesthesia. Both systems give reproducible immobilisation to complement the high-precision treatment delivery. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:289 / 297
页数:9
相关论文
共 50 条
  • [1] Feasibility of fractionated stereotactically-guided conformal radiotherapy in children.
    Shepherd, SF
    Cosgrove, VP
    Warrington, AP
    Brada, M
    BRITISH JOURNAL OF CANCER, 1996, 74 : 42 - 42
  • [2] Stereotactically guided conformal radiotherapy for meningiomas
    Alheit, H
    Saran, FH
    Warrington, AP
    Rosenberg, I
    Perks, J
    Jalali, R
    Shepherd, S
    Beardmore, C
    Baumert, B
    Brada, M
    RADIOTHERAPY AND ONCOLOGY, 1999, 50 (02) : 145 - 150
  • [3] Results of three-dimensional stereotactically-guided radiotherapy in recurrent medulloblastoma
    Milker-Zabel, S
    Zabel, A
    Thilmann, C
    Zuna, I
    Hoess, A
    Wannenmacher, M
    Debus, J
    JOURNAL OF NEURO-ONCOLOGY, 2002, 60 (03) : 227 - 233
  • [4] Results of Three-dimensional Stereotactically-guided Radiotherapy in Recurrent Medulloblastoma
    Stefanie Milker-Zabel
    Angelika Zabel
    Christoph Thilmann
    Ivan Zuna
    Angelika Hoess
    Michael Wannenmacher
    Jürgen Debus
    Journal of Neuro-Oncology, 2002, 60 : 227 - 233
  • [5] Results of three-dimensional stereotactically-guided radiotherapy in recurrent medulloblastoma
    Milker-Zabel, S
    Thilmann, CJ
    Zuna, I
    Hoess, A
    Wannenmacher, M
    Debus, J
    RADIOLOGY, 2001, 221 : 551 - 551
  • [6] The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma
    Zabel, A
    Thilmann, C
    Milker-Zabe, S
    Schlegel, W
    Zuna, I
    Wannenmacher, M
    Debus, J
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (04) : 187 - 191
  • [7] Stereotactically guided conformal radiotherapy for meningiomas - Technique and early results.
    Saran, FH
    Perks, J
    Alheit, H
    Warrington, AP
    Rosenberg, I
    Beardmore, C
    Brada, M
    BRITISH JOURNAL OF CANCER, 1998, 78 : 7 - 7
  • [8] The Role of Stereotactically Guided Conformal Radiotherapy for Local Tumor Control of Esthesioneuroblastoma
    Angelika Zabel
    Christoph Thilmann
    Stefanie Milker-Zabel
    Wolfgang Schlegel
    Ivan Zuna
    Michael Wannenmacher
    Jürgen Debus
    Strahlentherapie und Onkologie, 2002, 178 : 187 - 191
  • [9] Patient position reproducibility in fractionated stereotactically guided conformal radiotherapy using the BrainLab® mask system
    Alheit, H
    Dornfeld, S
    Dawel, M
    Alheit, M
    Henzel, B
    Steckler, K
    Blank, H
    Geyer, P
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (05) : 264 - 268
  • [10] Patient Position Reproducibility in Fractionated Stereotactically Guided Conformal Radiotherapy Using the BrainLab® Mask System
    Horst Alheit
    Sylvia Dornfeld
    Monic Dawel
    Michaela Alheit
    Birgit Henzel
    Kerstin Steckler
    Hilbert Blank
    Peter Geyer
    Strahlentherapie und Onkologie, 2001, 177 : 264 - 268